Poly‐gene fusion transcripts and chromothripsis in prostate cancer

Complex genome rearrangements are frequently observed in cancer but their impact on tumor molecular biology is largely unknown. Recent studies have identified a new phenomenon involving the simultaneous generation of tens to hundreds of genomic rearrangements, called chromothripsis. To understand the molecular consequences of these events, we sequenced the genomes and transcriptomes of two prostate tumors exhibiting evidence of chromothripsis. We identified several complex fusion transcripts, each containing sequence from three different genes, originating from different parts of the genome. One such poly‐gene fusion transcript appeared to be expressed from a chain of small genomic fragments. Furthermore, we detected poly‐gene fusion transcripts in the prostate cancer cell line LNCaP, suggesting they may represent a common phenomenon. Finally in one tumor with chromothripsis, we identified multiple mutations in the p53 signaling pathway, expanding on recent work associating aberrant DNA damage response mechanisms with chromothripsis. Overall, our data show that chromothripsis can manifest as massively rearranged transcriptomes. The implication that multigenic changes can give rise to poly‐gene fusion transcripts is potentially of great significance to cancer genetics. © 2012 Wiley Periodicals, Inc.

[1]  C. Cooper,et al.  ETS gene fusions in prostate cancer , 2009, Nature Reviews Urology.

[2]  Steven J. M. Jones,et al.  Circos: an information aesthetic for comparative genomics. , 2009, Genome research.

[3]  M. Hegde,et al.  Multiple tumors in a child with germ-line mutations in TP53 and PTEN. , 2008, The New England journal of medicine.

[4]  F. Hormozdiari,et al.  Comrad : a novel algorithmic framework for the integrated analysis of RNA-Seq and WGSS data , 2011 .

[5]  V. Daggett,et al.  Structural effects of the L145Q, V157F, and R282W cancer-associated mutations in the p53 DNA-binding core domain. , 2011, Biochemistry.

[6]  Rafael J. Yáñez-Muñoz,et al.  Chromosome rearrangement associated inactivation of tumour suppressor genes in prostate cancer. , 2011, American journal of cancer research.

[7]  Benjamin J. Raphael,et al.  Decoding the fine-scale structure of a breast cancer genome and transcriptome. , 2006, Genome research.

[8]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[9]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[10]  R. Wilson,et al.  Chromothripsis and Human Disease: Piecing Together the Shattering Process , 2012, Cell.

[11]  David E. Williams,et al.  Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. , 2010, Cancer cell.

[12]  R. Shah,et al.  Role of the TMPRSS2-ERG gene fusion in prostate cancer. , 2008, Neoplasia.

[13]  S. C. Sahinalp,et al.  nFuse: Discovery of complex genomic rearrangements in cancer using high-throughput sequencing , 2012, Genome research.

[14]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[15]  S. Henikoff,et al.  Predicting deleterious amino acid substitutions. , 2001, Genome research.

[16]  N. Carter,et al.  Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development , 2011, Cell.

[17]  J. Tchinda,et al.  Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer , 2005, Science.

[18]  C. Sander,et al.  Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.

[19]  Lior Pachter,et al.  Sequence Analysis , 2020, Definitions.

[20]  Markus J. van Roosmalen,et al.  Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. , 2011, Human molecular genetics.

[21]  S. Smith,et al.  Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Cuzick,et al.  Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer , 2008, British Journal of Cancer.

[23]  S. Luo,et al.  Chimeric transcript discovery by paired-end transcriptome sequencing , 2009, Proceedings of the National Academy of Sciences.

[24]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[25]  M. Olivier,et al.  Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.

[26]  Markus J. van Roosmalen,et al.  Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer , 2011, Genome Biology.

[27]  Eric S. Lander,et al.  The genomic complexity of primary human prostate cancer , 2010, Nature.

[28]  Stephen J. Salipante,et al.  Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers , 2011, Proceedings of the National Academy of Sciences.

[29]  S. Dhanasekaran,et al.  Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.

[30]  David T. W. Jones,et al.  Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.

[31]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[32]  K. Chin,et al.  End-sequence profiling: Sequence-based analysis of aberrant genomes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. Børresen-Dale,et al.  COMPLEX LANDSCAPES OF SOMATIC REARRANGEMENT IN HUMAN BREAST CANCER GENOMES , 2009, Nature.

[34]  N. Munshi,et al.  Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. , 2011, Blood.

[35]  Faraz Hach,et al.  Comrad: detection of expressed rearrangements by integrated analysis of RNA-Seq and low coverage genome sequence data , 2011, Bioinform..

[36]  A. Chinnaiyan,et al.  The emergence of lncRNAs in cancer biology. , 2011, Cancer discovery.

[37]  S. Kato,et al.  Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  H. Hakonarson,et al.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.

[39]  Robert H. Bell,et al.  From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer , 2012, The Journal of pathology.

[40]  M. Gleave,et al.  MicroRNAs Associated with Metastatic Prostate Cancer , 2011, PloS one.

[41]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[42]  P. Stankiewicz,et al.  Chromosome Catastrophes Involve Replication Mechanisms Generating Complex Genomic Rearrangements , 2011, Cell.

[43]  Lee T. Sam,et al.  Transcriptome Sequencing to Detect Gene Fusions in Cancer , 2009, Nature.

[44]  Süleyman Cenk Sahinalp,et al.  deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..

[45]  Laurence H. Pearl,et al.  Structure and function of the Rad9-binding region of the DNA-damage checkpoint adaptor TopBP1 , 2010, Nucleic Acids Res..

[46]  M. Eilers,et al.  Fbw7 and Usp28 Regulate Myc Protein Stability in Response to DNA Damage , 2007, Cell cycle.

[47]  Francesca Demichelis,et al.  Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. , 2011, Genome research.

[48]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[49]  Wei Yan,et al.  Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer. , 2011, Cancer cell.

[50]  Steven J. M. Jones,et al.  Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer , 2012, The Journal of pathology.

[51]  P. Pandolfi,et al.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.